Serum/glucocorticoid related kinase 1 (SGK1) is upregulated in the brains of patients with various neurodegenerative disorders such as PD and pharmacological inhibition of SGK1 limits NLRP3-inflammasome- and cGAS-STING-mediated inflammatory pathways (124). Here, SGK1 is linked to Parkinson disease.